These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 14719558

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions.
    Hattenbach LO, Klais C, Koch FH, Gümbel HO.
    Ophthalmology; 2001 Aug; 108(8):1485-92. PubMed ID: 11470706
    [Abstract] [Full Text] [Related]

  • 4. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
    Kung YH, Wu TT, Hong MC, Sheu SJ.
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578
    [Abstract] [Full Text] [Related]

  • 5. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.
    Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS.
    Arch Ophthalmol; 2001 Jan; 119(1):28-32. PubMed ID: 11146723
    [Abstract] [Full Text] [Related]

  • 6. Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.
    Guthoff R, Guthoff T, Meigen T, Goebel W.
    Retina; 2011 Jan; 31(1):36-40. PubMed ID: 20921929
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.
    Hesse L, Schmidt J, Kroll P.
    Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):273-7. PubMed ID: 10208258
    [Abstract] [Full Text] [Related]

  • 10. Long-term visual outcome and its predictive factors following treatment of acute submacular hemorrhage with intravitreous injection of tissue plasminogen factor and gas.
    Sobolewska B, Utebey E, Bartz-Schmidt KU, Tatar O.
    J Ocul Pharmacol Ther; 2014 Sep; 30(7):567-72. PubMed ID: 24821566
    [Abstract] [Full Text] [Related]

  • 11. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC.
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
    Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC.
    Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
    [Abstract] [Full Text] [Related]

  • 14. Intravitreous tissue plasminogen activator injection and pneumatic displacement in the management of submacular hemorrhage complicating scleral buckling procedures.
    Chen SN, Ho CL, Kuo YH, Ho JD.
    Retina; 2001 Jun; 21(5):460-3. PubMed ID: 11642374
    [Abstract] [Full Text] [Related]

  • 15. Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais.
    Ratanasukon M, Kittantong A.
    Eye (Lond); 2005 Dec; 19(12):1328-32. PubMed ID: 15565185
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage secondary to retinal artery macroaneurysm.
    Wu TT, Sheu SJ.
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):62-7. PubMed ID: 15718829
    [Abstract] [Full Text] [Related]

  • 19. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.
    Thompson JT, Sjaarda RN.
    Trans Am Ophthalmol Soc; 2005 Feb; 103():98-107; discussion 107. PubMed ID: 17057793
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.